Experimental RNA drug slashes harmful cholesterol levels in early human trial
A single dose of Kylo-11 was well tolerated, and at doses of 225 mg or higher, durably reduced serum lipoprotein(a) concentrations up to 48 weeks.
A single dose of Kylo-11 was well tolerated, and at doses of 225 mg or higher, durably reduced serum lipoprotein(a) concentrations up to 48 weeks.
Lipoprotein(a) is causally associated with an increased risk of atherosclerotic cardiovascular disease and calcific aortic valve stenosis.1 Clinical trials of proprotein convertase subtilisin/kexin…
Scientists have created light-activated drugs that helped blind mice perceive light again and restored visually guided behavior without gene therapy, implants, or specialized lighting. Even more…
A popular vanilla flavoring in e-cigarettes may interfere with some of the earliest steps of human development. In lab experiments, vanillin caused embryonic stem cells to lose their ability to…
New England Journal of Medicine, Ahead of Print. <br/>
Every one of 212 plant-based meat alternatives and drinks tested in the UK contained at least one naturally occurring fungal toxin, though concentrations remained below recommended EU guideline…
According to a master’s thesis at the Norwegian University of Science and Technology (NTNU), a mobile game can make physical activity more enjoyable. Two master’s students investigated how the mobile…
Wildlife farming is common in Vietnam, where people breed and trade wild animals for pets, food and traditional medicine.
The mild cognitive impairment (MCI) continuum represents a critical stage in the Alzheimer’s disease (AD), yet much of the genetic determinants underlying early neural dysfunction in AD remain…
Transcriptome-wide association studies (TWAS) can identify genes where genetically predicted gene expression is associated with disease risk, but translating those signals into therapeutic…